Literature DB >> 16362897

Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice.

Nicolas F Delahaye1, Nicolas Coltel, Denis Puthier, Laurence Flori, Remi Houlgatte, Fuad A Iraqi, Catherine Nguyen, Georges E Grau, Pascal Rihet.   

Abstract

The development of cerebral malaria (CM) in mice with Plasmodium berghei ANKA infection is under genetic control. Brain gene-expression patterns were investigated in well-defined genetically CM-resistant (CM-R; BALB/c and DBA/2) and CM-susceptible (CM-S; C57BL/6 and CBA/J) mice by use of cDNA microarrays. By combining transcriptional profiling with rigorous statistical methods and cluster analysis, we identified a set of 69 genes that perfectly discriminated between mouse strains and between CM-R and CM-S mice. The analysis of gene ontological terms revealed that the genes that clustered and were related to susceptibility to CM preferentially belonged to some biological process classes, such as those pertaining to immune responses. Using a false discovery rate of 5% and the Welch t test, we identified 31 genes with consistent differential expression between CM-R and CM-S mice. These data indicate that microarray analysis may be useful for identification of candidate genes that are potentially responsible for resistance or susceptibility to mouse CM and suggest that candidate genes identified in mice could be specifically tested in humans for an association with disease severity.

Entities:  

Mesh:

Year:  2005        PMID: 16362897     DOI: 10.1086/498579

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Cerebral malaria pathogenesis: what can we learn from microarray analysis?

Authors:  Chandy C John
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

2.  Cerebral tissue oxygenation impairment during experimental cerebral malaria.

Authors:  Pedro Cabrales; Yuri C Martins; Peng Kai Ong; Graziela M Zanini; John A Frangos; Leonardo J M Carvalho
Journal:  Virulence       Date:  2013-09-11       Impact factor: 5.882

3.  Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Xianzhen Hu; Oliver Billker; Julian C Rayner; Malika Ahras; Jillian E Wohler; Scott R Barnum
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

4.  Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria.

Authors:  Fiona E Lovegrove; Sina A Gharib; Samir N Patel; Cheryl A Hawkes; Kevin C Kain; W Conrad Liles
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

5.  Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.

Authors:  Sylvie Briquet; Nadou Lawson-Hogban; Bertrand Boisson; Miguel P Soares; Roger Péronet; Leanna Smith; Robert Ménard; Michel Huerre; Salah Mécheri; Catherine Vaquero
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

6.  VEGF promotes malaria-associated acute lung injury in mice.

Authors:  Sabrina Epiphanio; Marta G Campos; Ana Pamplona; Daniel Carapau; Ana C Pena; Ricardo Ataíde; Carla A A Monteiro; Nuno Félix; Artur Costa-Silva; Claudio R F Marinho; Sérgio Dias; Maria M Mota
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

7.  Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.

Authors:  J Brian de Souza; Uduak Okomo; Neal D Alexander; Naveed Aziz; Benjamin M J Owens; Harparkash Kaur; Momodou Jasseh; Sant Muangnoicharoen; Percy F Sumariwalla; David C Warhurst; Stephen A Ward; David J Conway; Luis Ulloa; Kevin J Tracey; Brian M J Foxwell; Paul M Kaye; Michael Walther
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

8.  A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria.

Authors:  Ryan W Carroll; Mark S Wainwright; Kwang-Youn Kim; Trilokesh Kidambi; Noé D Gómez; Terrie Taylor; Kasturi Haldar
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

9.  Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis.

Authors:  Jenny Miu; Nicholas H Hunt; Helen J Ball
Journal:  Infect Immun       Date:  2008-02-25       Impact factor: 3.441

10.  Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities.

Authors:  Louise M Randall; Fiona H Amante; Karli A McSweeney; Yonghong Zhou; Amanda C Stanley; Ashraful Haque; Malcolm K Jones; Geoff R Hill; Glen M Boyle; Christian R Engwerda
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.